| Clinical status | Demographic | Biochemical and virological | |||||||
---|---|---|---|---|---|---|---|---|---|---|
characteristics | characteristics | |||||||||
 | HCC (13) | ASC (24) | CR (33) | AH (7) | CH (4) | Male: Female | Age mean ±SD | ALT median IU/L (IQR) | HBeAg positive (%) | Viral loads log median IU/ml (IQR) |
Genotype D (%) | 4(30.7) | 14(58.3) | 23(69.7) | 4(57.1) | 3(75) | 38:10 | 44.6 ±15.1 | 29 (19–57) | 4 (8.3) | 2.8 (2.0-3.9) |
Genotype E (%) | 6(46.2) | 6(25) | 8(24.3) | 3(42.9) | 1(25) | 17:07 | 49.3 ±14.3 | 29 (18–65) | 7 (29.2)a | 4 (2.6-5.7)a |
Genotype D/E (%) | 1(7.7) | 0 | 1(3) | 0 | 0 | 2:0 | 56.5 ±7.0 | NA | 0 | 2.4 (2.3-2.41) |
Genotype A (%) | 2(15.4) | 4(16.7) | 1(3) | 0 | 0 | 5:2 | 38.14 ±14.51 | 33 (28–54) | 1 (14.3) | 2.6 (2.3-3.9) |